| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/25/2010 | US7723311 Delivery of bioactive substances to target cells |
| 05/25/2010 | US7723298 Cytokine receptor |
| 05/25/2010 | US7723293 administering to the heart of subject in need of increased capillary density in the heart a trk receptor ligand in an amount effective to increase capillary density in the heart, said trk receptor ligand being selected from the group consisting of brain-derived neurotrophic factor, NT-3, and NT-4. |
| 05/25/2010 | US7723288 Methods and compositions for the treatment of neurological disease |
| 05/25/2010 | US7723270 comprises a filamentous bacteriophage particle displaying on its surface a binding molecule which has a binding domain able to bind target epitope or antigen; genetic engineering |
| 05/25/2010 | US7723269 Process for selecting anti-angiogenesis antibody fragments, anti-angiogenesis antibody fragments thus obtained and their use |
| 05/25/2010 | US7723111 Anticancer agents; autoimmune disease |
| 05/25/2010 | US7723110 Plant cell signaling genes |
| 05/25/2010 | US7723109 Expression of spider silk proteins |
| 05/25/2010 | US7723104 Polynucleotide construct having a prostate cancer-specific control sequence including at least 2 of a prostate tissue-specific control sequence; a cancer-specific control sequence; and a two-step transcriptional amplification sequence including a DNA binding domain and an activation domain |
| 05/25/2010 | US7723103 Plasmid comprising single stranded overhangs for use in replication of preferential gene sequences |
| 05/25/2010 | US7723102 Mammalian cell gene expression vector system for use as tool in the transfer and expression of heterologous proteins in cells |
| 05/25/2010 | US7723098 Method of constructing host and method of producing heterologous protein |
| 05/25/2010 | US7723097 Strains in which an aspartate semialdehyde dehydrogenase gene is operably associated with at least one non-native promoter, non-native ribosome binding site, or both; novel plasmid |
| 05/25/2010 | US7723096 Agonist peptides of carcinoembryonic antigen (CEA) and nucleic acid sequences encoding the agonist peptides |
| 05/25/2010 | US7723094 Recombinant influenza vectors with a polII promoter and ribozymes for vaccines and gene therapy |
| 05/25/2010 | US7723093 Used for removing cross contamination from PCR reaction products byreacting a uracil-containing DNA substrate with the uracil-DNA glycosylase at 50 degrees C. or lower, and conducting PCR reaction. |
| 05/25/2010 | US7723092 Chondroitin polymerase and DNA encoding the same |
| 05/25/2010 | US7723091 combination of a mannanase and a carrier that is adapted for oral administration and does not contain an anti-infection agent other than the mannanase; treating or ameliorating the risk of a digestive tract infection, particularly of Eimeria, Cryptosporidium, or Clostridium |
| 05/25/2010 | US7723087 Preparing transgenic microorganism comprising modified intercellular adhesion (ica) locus and which generates cell surface proteins with altered poly-N-acetyl glucosamine (PNAG) side chain profile for use in vaccine development; bactericides |
| 05/25/2010 | US7723081 Intracellular activity of enzymes including dihydrodipicolinate synthase,aspartokinase, dihydrodipicolinate reductase, nicotinamide adenine dinucleotide transhydrogenase is enhanced by introducing one or more promoters linked to the gene encoding the enzymes into the chromosome of Eschericia coli |
| 05/25/2010 | US7723080 Murine α (1,3) fucosyltransferase Fuc-TVII, DNA encoding the same, method for preparing the same, antibodies recognizing the same, immunoassays for detecting the same, plasmids containing such DNA, and cells containing such a plasmid |
| 05/25/2010 | US7723078 Using hepatitis b virus specific primers to replicate targeted viral gene sequences |
| 05/25/2010 | US7723077 In vitro recombination method |
| 05/25/2010 | US7723074 Nucleic acid molecules encoding prostaglandin receptor proteins |
| 05/25/2010 | US7723073 Nucleic acid sequences containing a coding sequence for a light chain of an anti-VLA-1 antibody or antigen binding fragment, and a coding sequence for a heavy chain of an anti-VLA-1 antibody or fragment; the light chain and the heavy chain form an antibody or fragment that binds VLA-1 |
| 05/25/2010 | US7723071 DNA molecules encoding opioid receptors and methods of use thereof |
| 05/25/2010 | US7723070 Adding an desired amino acid analog to a medium containing a host cell with a vector coding for aminoacyl-tRNA synthetase and a vector coding for the polypeptide of interest; and growing the cell to produce the modified polypeptide |
| 05/25/2010 | US7723068 Gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 05/25/2010 | US7723067 Process for producing transglutaminase |
| 05/25/2010 | US7723051 HT2R75 taste receptor and related assays for identifying human bitter taste modulators |
| 05/25/2010 | US7723046 Method of screening for a compound using guanosine triphosphate (GTP)-binding protein-coupled receptor protein, BG37 |
| 05/25/2010 | US7723040 Detection of HIV-1 by nucleic acid amplification |
| 05/25/2010 | US7723039 Gene expression profiling from FFPE samples |
| 05/25/2010 | US7723035 detecting a reduction in gene copy number, by determining gene mutational status, or by detecting a reduction in the RNA transcribed from these genes; inhibition of neoplastic or tumorigenic growth of cancers such as chronic lymphocytic leukemia or prostate cancer cells |
| 05/25/2010 | US7723031 replication and amplification of target nucleic acid sequences, in the presence of a bacteriophage protein and a DNA polymerase; genetic engineering |
| 05/25/2010 | US7723025 detecting in the nucleic acids the presence of an A allele of a bovine stearoyl-CoA desaturase (SCD) gene to determine which bovine animal has high grade of meat, a higher percentage of monounsaturated fatty acid |
| 05/25/2010 | US7723022 Oligonucleotide containing activated lymphocytes; antibody therap y; skin disorders; antiallergens; respiratory system disorders |
| 05/25/2010 | US7722887 detoxified and immunologically active heat-labile enterotoxin protein of Escherichia coli, wherein the serine residue at position 63 is substituted with tyrosine or amino acid residues at positions 110 and 112 are deleted; for development of a mucosal vaccine as well as a novel diarrheal vaccine |
| 05/25/2010 | US7722883 Genetic vaccine against PWD circovirus |
| 05/25/2010 | US7722880 polynucleotide encodes a protein for inducing an immune response; use as vaccines; drug targeting to specific protein; bactericides; veterinary medicine |
| 05/25/2010 | US7722876 Anti-idiotypic antibodies which recognise the idiotope of an antibody specific for a yeast killer toxin possess microbicidal activity |
| 05/25/2010 | US7722874 Methods for reducing T cell responsiveness to an autoantigen with anti-gp39 antibodies and antigen presenting cells |
| 05/25/2010 | US7722868 Agents that modulate the interaction of B7-1 polypeptide with PD-L1 and methods of use thereof |
| 05/25/2010 | US7722867 Nucleotide sequences coding chimeric immunoglobulin specific for epidermal growth factor receptor; treatment and prevention of cell proliferative disorders |
| 05/25/2010 | CA2491629C Enzyme-catalyzed in vitro modification and synthesis of nucleic acid using microwave irradiation |
| 05/25/2010 | CA2488697C Regulation of gene expression using chromatin remodelling factors |
| 05/25/2010 | CA2376666C Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications |
| 05/25/2010 | CA2375727C Cytofectin dimers and methods of use thereof |
| 05/25/2010 | CA2366187C A new class of enzymes in the biosynthetic pathway for the production of triacylglycerol and recombinant dna molecules encoding these enzymes |
| 05/25/2010 | CA2330237C Broad specificity dna damage endonuclease |
| 05/25/2010 | CA2321964C Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant virus |
| 05/25/2010 | CA2313248C Process for the production of naturally folded and secreted proteins by co-secretion of molecular chaperones |
| 05/25/2010 | CA2248243C Purification of tissue plasminogen activator (tpa) |
| 05/25/2010 | CA2241786C Novel amp activated protein kinase |
| 05/25/2010 | CA2238613C Consensus phytases |
| 05/25/2010 | CA2233538C Commercial production of aprotinin in plants |
| 05/25/2010 | CA2225189C Canine factor viii gene, protein and methods of use |
| 05/25/2010 | CA2223837C Aav transduction of myoblasts |
| 05/25/2010 | CA2218857C Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 05/25/2010 | CA2199715C Novel implant and novel vector for the treatment of acquired diseases |
| 05/25/2010 | CA2195446C Growth control for cells encapsulated within bioartificial organs |
| 05/25/2010 | CA2167178C Formation of and methods for the production of large bacillus thuringiensis crystals with increased pesticidal activity |
| 05/20/2010 | WO2010057217A1 Compositions and methods for increasing cellular uptake of rnai via sid-1 |
| 05/20/2010 | WO2010057175A1 Antibodies recognizing oxygen-regulated protein 150 expressed on cancer cells and methods of using same |
| 05/20/2010 | WO2010057152A2 Cross-species chimeric rna molecules |
| 05/20/2010 | WO2010057064A2 Engineering of yeast for cellulosic ethanol production |
| 05/20/2010 | WO2010057045A2 Regeneration of pancreatic islets and reversal of diabetes by islet transcription factor genes delivered in vivo |
| 05/20/2010 | WO2010057009A1 E. coli mediated gene silencing of beta-catenin |
| 05/20/2010 | WO2010056993A2 Prostate cancer biomarkers to predict recurrence and metastatic potential |
| 05/20/2010 | WO2010056982A2 Compositions and methods for identifying autism spectrum disorders |
| 05/20/2010 | WO2010056966A2 Novel hiv-2 isolate |
| 05/20/2010 | WO2010056831A2 Reprogramming a cell by inducing a pluripotent gene through use of an hdac modulator |
| 05/20/2010 | WO2010056816A2 βGI-IGG INTRON FOR ENHANCED ANTI-IGF1 R EXPRESSION |
| 05/20/2010 | WO2010056808A2 Compositions and methods for re-programming and re-differentiating cells |
| 05/20/2010 | WO2010056805A2 Gene knockout mesophilic and thermophilic organisms, and methods of use thereof |
| 05/20/2010 | WO2010056737A2 Methods and compositions involving mirnas in cancer stem cells |
| 05/20/2010 | WO2010056653A2 Proteases comprising one or more combinable mutations |
| 05/20/2010 | WO2010056519A1 Manipulation of glutamine synthetases (gs) to improve nitrogen use efficiency and grain yield in higher plants |
| 05/20/2010 | WO2010056513A2 Products and processes for multiplex nucleic acid identification |
| 05/20/2010 | WO2010056450A2 Electrotransformation of gram-positive, anaerobic, thermophilic bacteria |
| 05/20/2010 | WO2010056403A1 Branched cationic lipids for nucleic acids delivery system |
| 05/20/2010 | WO2010056374A2 Methods and compositions of molecular profiling for disease diagnostics |
| 05/20/2010 | WO2010056351A2 Gene expression classifiers for relapse free survival and minimal residual disease improve risk classification and out come prediction in pedeatric b-precursor acute lymphoblastic leukemia |
| 05/20/2010 | WO2010056148A1 Mucosal vaccine for immunotherapy of diseases caused by human papillomaviruses |
| 05/20/2010 | WO2010056107A2 Method for identification of a molecular marker linked to the shell gene of oil palm |
| 05/20/2010 | WO2010056093A1 Method for isolating the dna of the avian infectious laryngotracheitis virus for pcr analysis |
| 05/20/2010 | WO2010055929A1 Novel hsp90-targeted anti-cancer chimeric peptide |
| 05/20/2010 | WO2010055868A1 Method for detecting bacterium belonging to genus geosmithia |
| 05/20/2010 | WO2010055837A1 Gene capable of increasing quantity of plant biomass and method for utilizing same |
| 05/20/2010 | WO2010055789A1 Oligonucleotide derivative, labeling agent, and use of the labeling agent |
| 05/20/2010 | WO2010055666A1 Nitrile hydratase variant |
| 05/20/2010 | WO2010055413A1 Gene vector for inducing transgene-specific immune tolerance |
| 05/20/2010 | WO2010055307A1 Methods of enhancing translocation of charged analytes through transmembrane protein pores |
| 05/20/2010 | WO2010055292A2 Vectors |
| 05/20/2010 | WO2010055290A1 Method |
| 05/20/2010 | WO2010055208A1 Modified avidins binding to small ligands |
| 05/20/2010 | WO2010055186A1 Procedure for the production of transgenic plants presenting high antioxidant compound content, high antioxidant capacity and resistance to browning |
| 05/20/2010 | WO2010055148A2 Dosage of oligonucleotides suitable for the treatment of tumors |
| 05/20/2010 | WO2010055041A1 Compositions and methods for inhibiting expression of factor vii genes |